Qbtech AB – Trademark Portfolio
Entity Type: 98
Qbtech AB holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include QBTECH, QBTEST, QBCHECK, and QBCLINIC.
Cardellgatan 1
SE-114 36 Stockholm
Showing of trademarks Trademarks
Trademark Classifications
Qbtech AB's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Qbtech AB have?
Qbtech AB has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 1 abandoned, 1 cancelled.
What trademark classes does Qbtech AB file in?
Qbtech AB files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 9 (Computers & Electronics), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Qbtech AB's most well-known trademarks?
Qbtech AB's registered trademark portfolio includes well-known marks such as QBTECH, QBTEST, QBCHECK, and QBCLINIC. These are among 4 currently registered trademarks in the portfolio.
What is Qbtech AB's trademark registration success rate?
Qbtech AB has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.